Ulrich Canzler

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer

Isabelle Ray‐Coquard, Patricia Pautier, Sandro Pignata et al. · New England Journal of Medicine · 2019 · 2K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

Andreas du Bois, Anne Floquet, Jae‐Weon Kim et al. · Journal of Clinical Oncology · 2014 · 328 citations · Full text

Medicine, Oncology, Pharmacology +17

Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer

Philipp Harter, Jalid Sehouli, Annette Hasenburg et al. · International Journal of Gynecological Cancer · 2011 · 291 citations

Medicine, Oncology, Surgery +15

Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial

Josep M. del Campo, Ursula A. Matulonis, Susanne Malander et al. · Journal of Clinical Oncology · 2019 · 190 citations · Full text

Medicine, Oncology, Pharmacology +15

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 162 citations

Medicine, Gynecology, Oncology +14